Traci E Draucker, PA-C | |
912 Central Ave, Grant, NE 69140-3099 | |
(308) 352-7100 | |
(308) 352-7290 |
Full Name | Traci E Draucker |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 29 Years |
Location | 912 Central Ave, Grant, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821066705 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 664 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Perkins County Health Services | Grant, NE | Hospital |
Ogallala Community Hospital | Ogallala, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Perkins County Hospital District | 0840109823 | 18 |
News Archive
FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).
Many adults wish to maintain their independence as they age, but health problems often require them to live in assisted-care facilities where they can be observed by medical professionals. Now, technologies developed by University of Missouri researchers could help aging adults stay in their own homes longer while still being monitored by health care providers.
Large stores in California need not keep automated external defibrillators for customers who suffer heart attacks, the California Supreme Court decided. In a unanimous ruling Monday, the state's highest court said California law requires only that fitness centers have such potentially life-saving devices and encourages most public buildings to keep them (Dolan, 6/23).
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Traci E Draucker, PA-C 900 Lincoln Ave, Grant, NE 69140-3095 Ph: (308) 352-7100 | Traci E Draucker, PA-C 912 Central Ave, Grant, NE 69140-3099 Ph: (308) 352-7100 |
News Archive
FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).
Many adults wish to maintain their independence as they age, but health problems often require them to live in assisted-care facilities where they can be observed by medical professionals. Now, technologies developed by University of Missouri researchers could help aging adults stay in their own homes longer while still being monitored by health care providers.
Large stores in California need not keep automated external defibrillators for customers who suffer heart attacks, the California Supreme Court decided. In a unanimous ruling Monday, the state's highest court said California law requires only that fitness centers have such potentially life-saving devices and encourages most public buildings to keep them (Dolan, 6/23).
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
› Verified 4 days ago
Shannon Fisher, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 912 Central Ave, Grant, NE 69140 Phone: 308-352-7100 Fax: 308-352-7103 | |
Ms. Carol S. Cornelius, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 Lincoln Ave, Grant, NE 69140 Phone: 308-352-7200 Fax: 308-352-7290 |